(Adds missing words “in India” in paragraph 1)
March 31 (Reuters) – Danish drugmaker Novo Nordisk on Tuesday further slashed the price of its popular diabetes and weight-loss drugs Ozempic and Wegovy by as much as 36% and 48% in India to better compete as local drugmakers flood the market with cheaper generics.
($1 = 93.9890 Indian rupees)
(Reporting by Yagnoseni Das in Bengaluru; Editing by Devika Syamnath)
Brought to you by www.srnnews.com